TrialFrontiers in endocrinology2025

Impact of finerenone on chronic kidney disease progression in Chinese patients with type 2 diabetes: a FIGARO-DKD subgroup analysis.

Ping Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.